As of April 2024 Fulgent Genetics has a market cap of $0.61 Billion. This makes Fulgent Genetics the world's 5731th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2024 | $0.61 B | -27.96% |
2023 | $0.85 B | -4.82% |
2022 | $0.90 B | -70% |
2021 | $3.00 B | 104.4% |
2020 | $1.46 B | 429.74% |
2019 | $0.27 B | 381.09% |
2018 | $57.6 M | -26.21% |
2017 | $78.06 M | -61.83% |
2016 | $0.20 B |
On Apr 22nd, 2024 the market cap of Fulgent Genetics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
PAVmed
PAVM | $17.15 M | -97.22% | ๐บ๐ธ USA |
Philips PHG | $19.04 B | 2,985.72% | ๐ณ๐ฑ Netherlands |